Physician profile
Moses Kelley
NPI 1124156633
$1,027.78
in general payments reported to CMS, 2019-2025
18 companies · $96.86 in 2025
The $96.86 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $41.47 · 2021: $241 · 2022: $107 · 2023: $13.41 · 2024: $256 · 2025: $96.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $273.39 | 2019-2024 | |
| Abbott Laboratories | $170.55 | 2019-2021 | |
| Amgen INC. | $78.13 | 2021-2025 | Repatha |
| Pfizer INC. | $59.87 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $53.57 | 2021-2023 | Farxiga |
| Irhythm Technologies, INC. | $52.72 | 2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $43.59 | 2019-2022 | |
| Baxter Healthcare | $42.34 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Edwards Lifesciences Corporation | $36.29 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.14 | 2025 | |
| Philips North America LLC | $30.31 | 2024 | (Ck7) Extended Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.88 | 2025 | Jardiance |
| Elutia, INC. | $25.19 | 2021 | |
| Cardiovascular Systems INC. | $24.97 | 2019 | |
| Astellas Pharma US INC | $24.92 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $18.84 | 2024 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $16.02 | 2022 | |
| Merck Sharp & Dohme LLC | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moses Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.